Personalized Medicine

MBZUAI President, Professor Eric Xing and President of the Weizmann Institute, Professor Alon Chen in Abu Dhabi

A Senior Delegation from the Weizmann Institute of Science Visits MBZUAI Campus in Abu Dhabi

03.05.2021

Math & Computer Science, Computer Vision, Bioinformatics and Computational Biology, Astrophysics, Personalized Medicine, Genetics, Technology & Applications, Benefiting Humanity, Biotechnology

The two parties discussed their new collaboration initiative to advance the field of artificial intelligence research

melanoma cells

Bacteria May Aid Anti-Cancer Immune Response

17.03.2021

Bioinformatics and Computational Biology, Cancer, Personalized Medicine, Systems Biology, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics

The findings of a new study may explain the microbiome-immunotherapy connection

multiple myeloma drug resistant cells

Uncovering the Anti-Myeloma Resistance Files

22.02.2021

Cancer, Personalized Medicine, Immunology, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs

From bedside to bench and back: Researchers reveal a genetic signature that could help overcome drug resistance in some of the most aggressive forms...

Colon extracellular matrix

Stress Response Protein Links Inflammatory Disease to Colon Cancer

18.02.2021

Biochemistry, Cancer, Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics

The findings might help identify those at extra risk of this cancer and develop means of prevention

How Cancers Hurt Themselves to Hurt Immune Cells More

How Cancers Hurt Themselves to Hurt Immune Cells More

16.12.2020

Cancer, Personalized Medicine, Immunology

A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks

Drawing from the Same Deck

Drawing from the Same Deck

14.10.2020

Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics

The secrets of heart regeneration in chronic heart failure demonstrated in mice

pain response

Targeting a Chronic Pain Gateway Could Bring Relief

14.08.2020

Biochemistry, Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs

A new approach to chronic pain treatment targets a molecule that moves pain messages into nerve cell nuclei

contract sign

Weizmann Institute of Science and Schneider Children’s Medical Center of Clalit Health Services to Collaborate

30.07.2020

Life Sciences, Personalized Medicine

The two aim to establish the Schneider-Weizmann Center for Research on Child and Adult Health

Tissue sample from triple-negative breast cancer, stained for the presence of cancer cells (red) and the two types of cancer-associated fibroblasts: pCAFs (magenta) and sCAFs (green). The nuclei of all cells are stained blue

Cancer “Helpers” Come in Different Types

23.07.2020

Biochemistry, Cancer, Personalized Medicine

Supporting actors in cancer growth may help predict the course of the disease

Lung cancer samples: Far left untreated. Lung cancer tissue failed to respond when exposed to a microtubule inhibitor drug (left) or to a drug that enhanced the apoptosis-inducing pathway (middle). But when the two drugs were applied together to the same tissue, the cancer cells died (right)

A New Approach to Tailoring Cancer Therapy: Tapping into Signaling Activities in Cancer Cells

16.07.2020

Cancer, Personalized Medicine, Systems Biology, Disease, Drugs & Diagnostics

Matching drugs to tumors may lead to personalized treatment and new therapies

Pages

Top Stories

A Journey to the Center of the Liver

The Moon’s Dark Secret: Shadowed Cold Traps Could Unlock the Mystery of Lunar Ice

High-Rise Living: The Tiny Engineers that Build with Their Bodies

How Yeast Find the Perfect Match

Press Releases

A Journey to the Center of the Liver

The Moon’s Dark Secret: Shadowed Cold Traps Could Unlock the Mystery of Lunar Ice

How Yeast Find the Perfect Match